187 related articles for article (PubMed ID: 36361897)
21. Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases.
Fukami T; Kariya M; Kurokawa T; Iida A; Nakajima M
Eur J Pharm Sci; 2015 Oct; 78():47-53. PubMed ID: 26164127
[TBL] [Abstract][Full Text] [Related]
22. Age-Dependent Human Hepatic Carboxylesterase 1 (CES1) and Carboxylesterase 2 (CES2) Postnatal Ontogeny.
Hines RN; Simpson PM; McCarver DG
Drug Metab Dispos; 2016 Jul; 44(7):959-66. PubMed ID: 26825642
[TBL] [Abstract][Full Text] [Related]
23. Construction and Characterization of CRISPR/Cas9 Knockout Rat Model of Carboxylesterase 2a Gene.
Liu J; Shang X; Huang S; Xu Y; Lu J; Zhang Y; Liu Z; Wang X
Mol Pharmacol; 2021 Nov; 100(5):480-490. PubMed ID: 34503976
[TBL] [Abstract][Full Text] [Related]
24. Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril.
Zhu HJ; Appel DI; Johnson JA; Chavin KD; Markowitz JS
Biochem Pharmacol; 2009 Apr; 77(7):1266-72. PubMed ID: 19185566
[TBL] [Abstract][Full Text] [Related]
25. Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis.
Laizure SC; Parker RB; Herring VL; Hu ZY
Drug Metab Dispos; 2014 Feb; 42(2):201-6. PubMed ID: 24212379
[TBL] [Abstract][Full Text] [Related]
26. Carboxylesterase-2 plays a critical role in dabigatran etexilate active metabolite formation.
Laizure SC; Chen F; Farrar JE; Ali D; Yang B; Parker RB
Drug Metab Pharmacokinet; 2022 Dec; 47():100479. PubMed ID: 36375226
[TBL] [Abstract][Full Text] [Related]
27. Human Carboxylesterase 2 Reverses Obesity-Induced Diacylglycerol Accumulation and Glucose Intolerance.
Ruby MA; Massart J; Hunerdosse DM; Schönke M; Correia JC; Louie SM; Ruas JL; Näslund E; Nomura DK; Zierath JR
Cell Rep; 2017 Jan; 18(3):636-646. PubMed ID: 28099843
[TBL] [Abstract][Full Text] [Related]
28. Development of a Caco-2 Cell Line Carrying the Human Intestine-Type CES Expression Profile as a Promising Tool for Ester-Containing Drug Permeability Studies.
Ishizaki Y; Furihata T; Oyama Y; Ohura K; Imai T; Hosokawa M; Akita H; Chiba K
Biol Pharm Bull; 2018; 41(5):697-706. PubMed ID: 29709907
[TBL] [Abstract][Full Text] [Related]
29. Clinical implications of genetic variation in carboxylesterase drug metabolism.
Chen F; Zhang B; Parker RB; Laizure SC
Expert Opin Drug Metab Toxicol; 2018 Feb; 14(2):131-142. PubMed ID: 29264996
[TBL] [Abstract][Full Text] [Related]
30. Identification of a novel intracellular cholesteryl ester hydrolase (carboxylesterase 3) in human macrophages: compensatory increase in its expression after carboxylesterase 1 silencing.
Zhao B; Bie J; Wang J; Marqueen SA; Ghosh S
Am J Physiol Cell Physiol; 2012 Aug; 303(4):C427-35. PubMed ID: 22700792
[TBL] [Abstract][Full Text] [Related]
31. Identification and Characterization of a New Carboxylesterase 2 Isozyme, mfCES2C, in the Small Intestine of Cynomolgus Monkeys.
Ohura K; Igawa Y; Tanaka M; Matsumoto K; Kasahara A; Wada N; Kubota K; Uno Y; Imai T
Drug Metab Dispos; 2020 Mar; 48(3):146-152. PubMed ID: 31836607
[TBL] [Abstract][Full Text] [Related]
32. Different hydrolases involved in bioactivation of prodrug-type angiotensin receptor blockers: carboxymethylenebutenolidase and carboxylesterase 1.
Ishizuka T; Yoshigae Y; Murayama N; Izumi T
Drug Metab Dispos; 2013 Nov; 41(11):1888-95. PubMed ID: 23946449
[TBL] [Abstract][Full Text] [Related]
33. Hydrolase activities of cynomolgus monkey liver microsomes and recombinant CES1, CES2, and AADAC.
Honda S; Fukami T; Tsujiguchi T; Zhang Y; Nakano M; Nakajima M
Eur J Pharm Sci; 2021 Jun; 161():105807. PubMed ID: 33722734
[TBL] [Abstract][Full Text] [Related]
34. In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors.
Thomsen R; Rasmussen HB; Linnet K;
Drug Metab Dispos; 2014 Jan; 42(1):126-33. PubMed ID: 24141856
[TBL] [Abstract][Full Text] [Related]
35. Biochemical and molecular analysis of carboxylesterase-mediated hydrolysis of cocaine and heroin.
Hatfield MJ; Tsurkan L; Hyatt JL; Yu X; Edwards CC; Hicks LD; Wadkins RM; Potter PM
Br J Pharmacol; 2010 Aug; 160(8):1916-28. PubMed ID: 20649590
[TBL] [Abstract][Full Text] [Related]
36. Carboxylesterases 1 and 2 hydrolyze phospho-nonsteroidal anti-inflammatory drugs: relevance to their pharmacological activity.
Wong CC; Cheng KW; Xie G; Zhou D; Zhu CH; Constantinides PP; Rigas B
J Pharmacol Exp Ther; 2012 Feb; 340(2):422-32. PubMed ID: 22085648
[TBL] [Abstract][Full Text] [Related]
37. Arylacetamide Deacetylase is Responsible for Activation of Prasugrel in Human and Dog.
Kurokawa T; Fukami T; Yoshida T; Nakajima M
Drug Metab Dispos; 2016 Mar; 44(3):409-16. PubMed ID: 26718653
[TBL] [Abstract][Full Text] [Related]
38. 17β-estradiol suppresses carboxylesterases by activating c-Jun/AP-1 pathway in primary human and mouse hepatocytes.
Wu L; Hafiz MZ; Guan Y; He S; Xiong J; Liu W; Yan B; Li X; Yang J
Eur J Pharmacol; 2018 Jan; 819():98-107. PubMed ID: 29175444
[TBL] [Abstract][Full Text] [Related]
39. Indiplon is hydrolyzed by arylacetamide deacetylase in human liver.
Shimizu M; Fukami T; Ito Y; Kurokawa T; Kariya M; Nakajima M; Yokoi T
Drug Metab Dispos; 2014 Apr; 42(4):751-8. PubMed ID: 24464802
[TBL] [Abstract][Full Text] [Related]
40. Dexamethasone regulates differential expression of carboxylesterase 1 and carboxylesterase 2 through activation of nuclear receptors.
Zhang C; Gao P; Yin W; Xu Y; Xiang D; Liu D
J Huazhong Univ Sci Technolog Med Sci; 2012 Dec; 32(6):798-805. PubMed ID: 23271276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
